In one paragraphArticle in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Rawda Naamneh ElzenatyPediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.ORCID 0000-0003-2669-4170 Chrysanthi KouriPediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Idoia Martinez de LapiscinaPediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.ORCID 0000-0001-8943-1429 Kay-Sara SauterPediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Francisca MorenoDepartment of Pediatrics, Hospital Infantil La Fe, 46026 Valencia, Spain.
Núria Camats-TarruellaGrowth and Development Research Group, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.ORCID 0000-0002-4863-8201 Christa E FlückPediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Funding
Education Department of Basque Government, Spain POS_2020_1_0034Swiss National Science Foundation 320030-197725
6 · The paper itselfAbstract
Steroidogenic factor 1 (SF-1) is a nuclear receptor that regulates steroidogenesis and reproductive development.
Indexed as
InhibinsReceptors, AndrogenSteroidogenic Factor 1Disorder of Sex Development, 46,XYExome SequencingFemaleHumansMalePromoter Regions, GeneticAR protein, humaninhibin-alpha subunitInhibinsNR5A1 protein, humanReceptors, AndrogenSteroidogenic Factor 146,XY DSDandrogen receptordisorders of sex development (DSD)hypospadiasinhibin αoligogenicitysteroidogenic factor 1 (SF-1/NR5A1)
Identifiers
PMID39337600
PMCPMC11432463
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390